▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

ImmuCell (NASDAQ: ICCC)

$6.40

(4.6%)

$0.28

Price as of August 29, 2025, 4:00 p.m. ET

ImmuCell Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
ICCC	+67.98%	+25.74%	+4.68%	+540%
S&P	+15.53%	+84.16%	+12.97%	+1,466%

ImmuCell Company Info

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.

News & Analysis

Featured Article

ImmuCell Q2 Profit Jumps as Margins Rise

Motley Fool Markets Team | Aug 15, 2025

Featured Article

ImmuCell Posts 18% Gain in Q2

Motley Fool Markets Team | Aug 14, 2025

Valuation

Earnings Transcripts

ImmuCell ICCC Q2 2025 Earnings Call Transcript

None

Motley Fool Transcribing | Aug 15, 2025

ImmuCell (ICCC) Q2 2025 Earnings Call Transcript

None

Motley Fool Transcribing | Aug 15, 2025

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services